3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine

C68H63Br4N35O2S — CID 161054688

IUPAC3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.Cn1cc(-c2cnc3c(N)nc(-c4ccccc4)cn23)cn1.Cn1cc(-c2cnc3c(N)ncc(Br)n23)cn1.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1ncc(Br)n2ccnc12.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12
InChIInChI=1S/C16H14N6.C14H14BrN5O2S.C10H9BrN6.C10H10N6.2C6H5BrN4.C6H6N4/c1-21-9-12(7-19-21)14-8-18-16-15(17)20-13(10-22(14)16)11-5-3-2-4-6-11;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-16-5-6(2-15-16)7-3-14-10-9(12)13-4-8(11)17(7)10;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-5(8)6-9-1-2-11(4)6;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h2-10H,1H3,(H2,17,20);3-9H,1-2H3,(H,16,18);2-5H,1H3,(H2,12,13);2-6H,1H3,(H2,11,12);1-3H,(H2,8,10);1-3H,(H2,8,9);1-4H,(H2,7,8)
InChIKeyUCOZTTDOENBEJJ-UHFFFAOYSA-N
MW1754.18 g/mol
LogP9.51
Rot. Bonds8

About 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine

3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine (PubChem CID 161054688) has the molecular formula C68H63Br4N35O2S and a molecular weight of 1754.18 g/mol. Its IUPAC name is 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine.

Molecular Properties

Compound Name3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine
PubChem CID161054688
Molecular FormulaC68H63Br4N35O2S
Molecular Weight1754.18 g/mol
Exact Mass1749.24
IUPAC Name3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine
SMILESCN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.Cn1cc(-c2cnc3c(N)nc(-c4ccccc4)cn23)cn1.Cn1cc(-c2cnc3c(N)ncc(Br)n23)cn1.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1ncc(Br)n2ccnc12.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12
InChIInChI=1S/C16H14N6.C14H14BrN5O2S.C10H9BrN6.C10H10N6.2C6H5BrN4.C6H6N4/c1-21-9-12(7-19-21)14-8-18-16-15(17)20-13(10-22(14)16)11-5-3-2-4-6-11;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-16-5-6(2-15-16)7-3-14-10-9(12)13-4-8(11)17(7)10;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-5(8)6-9-1-2-11(4)6;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h2-10H,1H3,(H2,17,20);3-9H,1-2H3,(H,16,18);2-5H,1H3,(H2,12,13);2-6H,1H3,(H2,11,12);1-3H,(H2,8,10);1-3H,(H2,8,9);1-4H,(H2,7,8)
InChIKeyUCOZTTDOENBEJJ-UHFFFAOYSA-N
XLogP9.51
TPSA470.32 Ų
H-Bond Donors7
H-Bond Acceptors36
Rotatable Bonds8
Heavy Atoms110
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001754.18
LogP ≤ 59.51
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1036

Analyze 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine?
The IUPAC name of 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine (CID 161054688) is 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine.
What is the SMILES notation for 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine?
The canonical SMILES for 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine is CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(Br)cnc23)cc1.Cn1cc(-c2cnc3c(N)nc(-c4ccccc4)cn23)cn1.Cn1cc(-c2cnc3c(N)ncc(Br)n23)cn1.Cn1cc(-c2cnc3c(N)nccn23)cn1.Nc1ncc(Br)n2ccnc12.Nc1nccn2c(Br)cnc12.Nc1nccn2ccnc12.
What is the InChIKey of 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine?
The InChIKey is UCOZTTDOENBEJJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H14N6.C14H14BrN5O2S.C10H9BrN6.C10H10N6.2C6H5BrN4.C6H6N4/c1-21-9-12(7-19-21)14-8-18-16-15(17)20-13(10-22(14)16)11-5-3-2-4-6-11;1-19(2)23(21,22)11-5-3-10(4-6-11)18-13-14-17-9-12(15)20(14)8-7-16-13;1-16-5-6(2-15-16)7-3-14-10-9(12)13-4-8(11)17(7)10;1-15-6-7(4-14-15)8-5-13-10-9(11)12-2-3-16(8)10;7-4-3-10-5(8)6-9-1-2-11(4)6;7-4-3-10-6-5(8)9-1-2-11(4)6;7-5-6-9-2-4-10(6)3-1-8-5/h2-10H,1H3,(H2,17,20);3-9H,1-2H3,(H,16,18);2-5H,1H3,(H2,12,13);2-6H,1H3,(H2,11,12);1-3H,(H2,8,10);1-3H,(H2,8,9);1-4H,(H2,7,8).
What are the key properties of 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine?
3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine has a molecular weight of 1754.18 g/mol, XLogP of 9.51, 8 rotatable bonds, 7 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromoimidazo[1,2-a]pyrazin-8-amine;5-bromoimidazo[1,2-a]pyrazin-8-amine;4-[(3-bromoimidazo[1,2-a]pyrazin-8-yl)amino]-N,N-dimethylbenzenesulfonamide;5-bromo-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;3-(1-methylpyrazol-4-yl)-6-phenylimidazo[1,2-a]pyrazin-8-amine is sourced from PubChem (CID 161054688), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).